PFE (STOCKS)
Pfizer Inc.
$26.750000
+0.440000 (+1.67%)
Prev close: $26.310000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Albert Bourla
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $160,532.80M
- Employees
- 81,000
- P/E (TTM)
- 34.84
- P/B (TTM)
- 1.76
- Dividend Yield
- 653.74%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
20
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.77 | $0.69 | +0.0786 | +11.37% |
|
Mar 2026 (Q1)
|
$0.75 | $0.72 | +0.0257 | +3.55% |
|
Dec 2025 (Q4)
|
$0.66 | $0.58 | +0.0825 | +14.29% |
|
Sep 2025 (Q3)
|
$0.87 | $0.64 | +0.2303 | +36.00% |
Financial Statements
| Revenues | $63.70B |
| Benefits Costs and Expenses | $59.49B |
| Cost Of Revenue | $17.08B |
| Costs And Expenses | $59.49B |
| Gross Profit | $46.61B |
| Operating Expenses | $42.40B |
| Selling, General, and Administrative Expenses | $13.72B |
| Other Operating Expenses | $28.68B |
| Operating Income/Loss | $4.21B |
| Income/Loss From Continuing Operations After Tax | $4.37B |
| Income/Loss From Continuing Operations Before Tax | $4.21B |
| Income/Loss From Discontinued Operations Net Of Tax | -$5.00M |
| Income Tax Expense/Benefit | -$164.00M |
| Income Tax Expense/Benefit, Deferred | -$2.53B |
| Interest Expense, Operating | $2.70B |
| Net Income/Loss | $4.37B |
| Net Income/Loss Attributable To Noncontrolling Interest | $35.00M |
| Net Income/Loss Attributable To Parent | $4.33B |
| Net Income/Loss Available To Common Stockholders, Basic | $4.33B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.76 |
| Diluted Earnings Per Share | $0.76 |
| Basic Average Shares | 17,076,000,000 |
| Diluted Average Shares | 17,147,000,000 |
| Assets | $201.13B |
| Current Assets | $41.36B |
| Inventory | $9.95B |
| Other Current Assets | $31.41B |
| Noncurrent Assets | $159.77B |
| Fixed Assets | $19.03B |
| Intangible Assets | $47.05B |
| Other Non-current Assets | $93.69B |
| Liabilities | $115.64B |
| Current Liabilities | $32.65B |
| Accounts Payable | $4.58B |
| Wages | $2.55B |
| Other Current Liabilities | $25.51B |
| Noncurrent Liabilities | $82.99B |
| Equity | $85.49B |
| Equity Attributable To Noncontrolling Interest | $302.00M |
| Equity Attributable To Parent | $85.19B |
| Liabilities And Equity | $201.13B |
| Net Cash Flow From Operating Activities | $13.40B |
| Net Cash Flow From Operating Activities, Continuing | $13.40B |
| Net Cash Flow From Investing Activities | -$5.69B |
| Net Cash Flow From Investing Activities, Continuing | -$5.69B |
| Net Cash Flow From Financing Activities | -$8.40B |
| Net Cash Flow From Financing Activities, Continuing | -$8.40B |
| Exchange Gains/Losses | $22.00M |
| Net Cash Flow | -$662.00M |
| Net Cash Flow, Continuing | -$684.00M |
| Comprehensive Income/Loss | $5.56B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $11.00M |
| Comprehensive Income/Loss Attributable To Parent | $5.55B |
| Other Comprehensive Income/Loss | $1.20B |